Basic Information
RNALocate ID: RLID:11001971
RNA Symbol: hsa-miR-190a-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-190a
RNA ID: miRBase:MIMAT0000458
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24683445
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Exosomes are enriched with miRNA: Small RNA libraries of the samples described above were constructed for small RNA-seq by NGS. The number of miRNA identified in this study was 943 of 2,233 known mature miRNA from miRBase V.20. Mapping to Ensembl Release 74 was performed to identify other non-coding RNA such as tRNA, rRNA, small nucleolar RNA (snoRNA) and LincRNA. The average across all 3 samples was calculated to obtain a representative profile of biological diversity between patients (standard deviations of reads in Supplementary file).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11001968 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11001969 Exosome Brain tissue 23382797
RLID:11001970 Exosome Plasma 23663360
RLID:11001972 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID-D:11000386 Microvesicle Colon cancer cell line (LIM1863)|Mesenchymal stem cells|Urine
RLID-D:11001184 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-190a-5p Cardiomyopathies MNDR-E-MI-22104
MNDR hsa-miR-190a-5p Splenic marginal zone lymphoma MNDR-E-MI-22105
MNDR hsa-miR-190a-5p Multiple sclerosis chronic progressive MNDR-E-MI-22106
MNDR hsa-miR-190a-5p Medulloblastoma MNDR-E-MI-22107
MNDR hsa-miR-190a-5p Uterine corpus endometrial carcinoma MNDR-E-MI-22108
MNDR hsa-miR-190a-5p Lymphoma non-hodgkin MNDR-E-MI-22109
MNDR hsa-miR-190a-5p Estrogen-receptor positive breast cancer MNDR-E-MI-22110
MNDR hsa-miR-190a-5p Estrogen-receptor negative breast cancer MNDR-E-MI-22111
MNDR hsa-miR-190a-5p Progesterone-receptor positive breast cancer MNDR-E-MI-22112
MNDR hsa-miR-190a-5p Progesterone-receptor negative breast cancer MNDR-E-MI-22113
MNDR hsa-miR-190a-5p Her2-receptor positive breast cancer MNDR-E-MI-22114
MNDR hsa-miR-190a-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-22115
MNDR hsa-miR-190a-5p Dermatomyositis MNDR-E-MI-22116
MNDR hsa-miR-190a-5p Prostate cancer MNDR-E-MI-22117
MNDR hsa-miR-190a-5p Gastric cancer MNDR-E-MI-22118
MNDR hsa-miR-190a-5p Alzheimer disease MNDR-E-MI-22119
MNDR hsa-miR-190a-5p Esophageal carcinoma MNDR-E-MI-22120
MNDR hsa-miR-190a-5p Dysautonomia familial MNDR-E-MI-22121
MNDR hsa-miR-190a-5p Ataxia telangiectasia MNDR-E-MI-22122
MNDR hsa-miR-190a-5p Huntington disease MNDR-E-MI-22123
MNDR hsa-miR-190a-5p Lung cancer MNDR-E-MI-22124
MNDR hsa-miR-190a-5p Parkinson disease MNDR-E-MI-22125
MNDR hsa-miR-190a-5p Breast cancer MNDR-E-MI-22126
MNDR hsa-miR-190a-5p Thyroid cancer MNDR-E-MI-22127
MNDR hsa-miR-190a-5p Pancreatic cancer MNDR-E-MI-22128
MNDR hsa-miR-190a-5p Melanoma MNDR-E-MI-22129
MNDR hsa-miR-190a-5p Nephroblastoma MNDR-E-MI-22130
MNDR hsa-miR-190a-5p Colon cancer MNDR-E-MI-22131
MNDR hsa-miR-190a-5p Colon adenocarcinoma MNDR-E-MI-22132
MNDR hsa-miR-190a-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-22133
MNDR hsa-miR-190a-5p Ovarian neoplasms MNDR-E-MI-22134
MNDR hsa-miR-190a-5p Prostate adenocarcinoma MNDR-E-MI-22135
MNDR hsa-miR-190a-5p Carcinoma ductal breast MNDR-E-MI-22136
MNDR hsa-miR-190a-5p Glioblastoma MNDR-E-MI-22137
MNDR hsa-miR-190a-5p Glioma MNDR-E-MI-22138
MNDR hsa-miR-190a-5p Amyotrophic lateral sclerosis MNDR-E-MI-22139
MNDR hsa-miR-190a-5p Epilepsy temporal lobe MNDR-E-MI-22140
MNDR hsa-miR-190a-5p Liposarcoma MNDR-E-MI-22141
MNDR hsa-miR-190a-5p Inclusion body myositis MNDR-E-MI-22142
MNDR hsa-miR-190a-5p Meningioma MNDR-E-MI-22143
MNDR hsa-miR-190a-5p Uterine cancer MNDR-E-MI-22144
MNDR hsa-miR-190a-5p Gastric adenocarcinoma MNDR-E-MI-22145
MNDR hsa-miR-190a-5p Lung squamous cell carcinoma MNDR-E-MI-22146
MNDR hsa-miR-190a-5p Non-small cell lung adenocarcinoma MNDR-E-MI-22147
MNDR hsa-miR-190a-5p Lung adenocarcinoma MNDR-E-MI-22148
MNDR hsa-miR-190a-5p Thyroid carcinoma MNDR-E-MI-22149
MNDR hsa-miR-190a-5p Bladder urothelial carcinoma MNDR-E-MI-22150
MNDR hsa-miR-190a-5p Pancreatic adenocarcinoma MNDR-E-MI-22151
MNDR hsa-miR-190a-5p Carcinoma renal cell MNDR-E-MI-22152
MNDR hsa-miR-190a-5p Renal clear cell carcinoma MNDR-E-MI-22153
MNDR hsa-miR-190a-5p Esophageal cancer MNDR-E-MI-22154
MNDR hsa-miR-190a-5p HIV MNDR-E-MI-22155
MNDR hsa-miR-190a-5p Head and neck squamous cell carcinoma MNDR-E-MI-22156
MNDR hsa-miR-190a-5p Breast invasive carcinoma MNDR-E-MI-22157
MNDR hsa-miR-190a-5p Hepatocellular carcinoma MNDR-E-MI-22158
MNDR hsa-miR-190a-5p B-cell lymphoma MNDR-E-MI-22159
MNDR hsa-miR-190a-5p T-cell leukemia MNDR-E-MI-22160
MNDR hsa-miR-190a-5p Neuromyelitis optica MNDR-E-MI-22161
MNDR hsa-miR-190a-5p Acute myelogenous leukemia MNDR-E-MI-22162
MNDR hsa-miR-190a-5p Colorectal cancer MNDR-E-MI-22163
MNDR hsa-miR-190a-5p Acute lymphocytic leukemia MNDR-E-MI-22164
MNDR hsa-miR-190a-5p Ependymoma MNDR-E-MI-22165
MNDR hsa-miR-190a-5p Prostatic neoplasms MNDR-E-MI-22166
MNDR hsa-miR-190a-5p Arsenic poisoning MNDR-E-MI-22167
MNDR hsa-miR-190a-5p Stroke lacunar MNDR-E-MI-22168
MNDR hsa-miR-190a-5p Breast cancer her3+ negative MNDR-E-MI-22169
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CDKN1B Homo sapiens RR00311901
TOP